Atezolizumab,pembrolizumab,nivolumab,ipilimumab,durvalumab,tremelimumab
Roche,merck,bms,astrazeneca
['pembro', 'atezo', 'cisplatin', 'key,note,361', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'bladder', ' uc,(-ucsd),(-ucsf),']
updates by on io in metastatic #bladdercancer: combo of chemo + io did not work with atezo (pdl1) or pembro (pd1) chemo choice may make a difference, cisplatin may work better monotherapy io no longer an fda approved soc for 1l platinum eligible pts #gu23 
GU Oncologist | 🇨🇦 GU & NOLA Heme/Onc Alumni | Interested in GU, Immuno Onc & Med Ed | @ASCO Featured Voice | @TwoOncDocs podcast